Clinical trial design and new therapies for pulmonary arterial hypertension

Until 20 years ago the treatment of pulmonary arterial hypertension (PAH) was based on case reports and small series, and was largely ineffectual. As a deeper understanding of the pathogenesis and pathophysiology of PAH evolved over the subsequent two decades, coupled with epidemiological studies de...

Descripción completa

Detalles Bibliográficos
Autores principales: Sitbon, Olivier, Gomberg-Maitland, Mardi, Granton, John, Lewis, Michael I., Mathai, Stephen C., Rainisio, Maurizio, Stockbridge, Norman L., Wilkins, Martin R., Zamanian, Roham T., Rubin, Lewis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351342/
https://www.ncbi.nlm.nih.gov/pubmed/30545975
http://dx.doi.org/10.1183/13993003.01908-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351342/
https://www.ncbi.nlm.nih.gov/pubmed/30545975
http://dx.doi.org/10.1183/13993003.01908-2018

Ejemplares similares